L. reuteri NCIMB 30242

Lactobacillus reuteri NCIMB 30242 · Micropharma Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for L. reuteri NCIMB 30242, covering 2014-08-15 to 2014-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Effect of L. Reuteri NCIMB 30242 on Plasma Bile Acid Profile [Phase 2]